Better than 57% of Healthcare / Pharmaceuticals
Making progress starts at 46. The highest score on SINK is 71.
Is this your company? Claim this profile (free)
Buying from companies like this? Check 5 of your suppliers free
EssilorLuxottica designs, makes and sells spectacle lenses, frames and sunglasses under brands including Varilux, Transitions, Ray-Ban and Oakley, runs shops such as Sunglass Hut and LensCrafters, and makes Ray-Ban Meta and Oakley Meta smart glasses in partnership with Meta. In 2025 its wholesale business (Professional Solutions) brought in €13,600 million and its own shops and websites (Direct to Consumer) €14,891 million.
The legal company was formed on 6 October 1971 as Essilor and renamed EssilorLuxottica on the 2018 Luxottica combination; its roots go back to 1849, when the eyewear makers' cooperative that became Essel was founded in Paris. It employed 201,176 people at the end of 2025 and had €28,491 million revenue in 2025.
Founded 1971Head office Charenton-le-Pont, FranceStaff ~201,176 year-end (31 December 2025)Revenue ~€28.5B revenue (€28,491M, 2025)Website ↗
EssilorLuxottica's footprint was 4,645,220 tCO2e in 2025 (market-based), up from 4,423,644 t in 2024 and 4,126,729 t in 2022; it puts the rise down to med-tech acquisitions, growth in smart glasses and method changes. Purchased goods and services account for 2,270,840 t. Its 65% renewable energy figure rests almost entirely on certificates; on-site solar and biomass supply only a small share. SBTi validated its 2030 targets in December 2024: a 42% absolute cut in Scope 1 and 2 and 25% in selected Scope 3 from 2022. It has no net-zero target and no group water target. Part of long-term executive pay depends on total carbon emissions.
EssilorLuxottica scores 43/100 (Below expectations) on SINK's independent climate assessment, scored from public data only. Scores are free. Nobody can pay to change a score, speed it up or hide it. Last verified November 2026.
That places EssilorLuxottica joint 367th of 1,118 companies scored, and 11th of 24 in Healthcare / Pharmaceuticals.
Strongest on Carbon Footprint: Operations and Transparency & Accountability (8/10, 8/10). Weakest on Emissions Trajectory and Nature & Biodiversity Impact (0/10, 3/10).
For each question that lost points, the evidence our public rubric looks for that we didn't find.
What would raise this score
Every question that lost points
A score changes when the evidence does. We use new published evidence at the next rescore. Anyone can send us new evidence, free. How to send it.
Same ten questions for every company. No private weighting.
SINK = (0.3 × Base + 0.7 × Performance) × Scale11 sources used in this assessment. All publicly available. Each row shows which of the ten questions it informed.
27% of them were published by EssilorLuxottica itself; the rest come from independent sources.
“of the science-based target 500,429 591,647 591,647 704,686 (29%)”
“Financial Statements, as well as the Report on the Certification of Sustainability Information;”
“science based target to reduce greenhouse gas emissions in both its direct operations and supply chain but there’s no evidence it is on track”
“17. EssilorLuxottica 32”
“There’s no evidence it’s taking actions to protect biodiversity in its supply chain”
“The glasses aren't designed for disassembly or repair, making battery replacement virtually impossible for users or independent repair shops.”
“very clear that the first iterations of these smartglasses are going to be unrepairable.”
“sourced more than 1,000,000 MWh of renewable electricity through Energy Attribute Certificates (EACs)”
“alongside its SBTi-validated 2030 climate targets”
“Group’s revenue at Euro 28,491 million in the FY, +11.2% at constant exchange rates”
“TOTAL GHG EMISSIONS (MARKET-BASED) (tCOe) 4,119,953 4,126,729 (6,775)”
If you believe a source has been misread or a newer version exists, submit a challenge.
Use this score in tenders
Send the link, or the one-page score sheet. It links back to this page and every source. Free.
Open the score sheet →Send new evidence, free
Scored low because little is published? Publish what you do and send us the link, free. If it holds up, your score changes, and the change is logged on your page.
How to send evidence →Put your score on your website, free
It shows the current band, sector rank and score, and links to this page, so it changes when the score does.
Track this score
Bidding for a public contract? Check if you need a Carbon Reduction Plan, free →
Free, independent, every source shown. Send it to any buyer who asks about your sustainability.
Where EssilorLuxottica sits among healthcare / pharmaceuticals peers.
Among the 24 major healthcare / pharmaceuticals brands we've scored, EssilorLuxottica sits 11th of 24.
The 3 companies in the sector scoring nearest above EssilorLuxottica.
AstraZeneca has cut operational emissions 88% since 2015, but Scope 3 has risen 24% above baseline and now comprises 99% of total footprint.
See the breakdown →Sanofi's own emissions are 49% below 2019, but its total of 4.45 MtCO2e was flat in 2025 because its supply-chain emissions rose slightly.
See the breakdown →Hikma publishes a full Scope 3 inventory (863,128 tCO2e in 2025, mostly purchased goods and services) and has reasonable assurance on its Scope 1 and 2, but its Scope 1 and 2 emissions rose in 2025 and Scope 3 rose slightly.
See the breakdown →One email, every Sunday. Score changes, new research, the stories behind the numbers. Free.
We'll send one email to confirm. No spam. Unsubscribe in one click.
Checking a company?
Search free →Asked to prove you're sustainable?
Get your business scored, free →Been scored?
Find your page and claim it, free →Scores are free. Nobody can pay to change a score, speed it up or hide it.